In vitro activity of anidulafungin against selected clinically important mold isolates

Zekaver Odabasi1, Victor L Paetznick, Jose R Rodriguez

  • 1Laboratory of Mycology Research, Division of Infectious Diseases, University of Texas-Houston Medical School, Houston, Texas 77030, USA.

Insights

Anidulafungin demonstrated effective in vitro antifungal activity against several significant mold species. This research highlights its potential for treating mold infections caused by Bipolaris spicifera and Fonsecaea pedrosoi.

Area of Science:

  • Mycology
  • Antifungal Research
  • Infectious Diseases

Background:

  • Mold infections pose a significant clinical challenge, often requiring effective antifungal therapies.
  • Echinocandin antifungals, like anidulafungin, are crucial in managing invasive fungal infections.
  • Limited data exists on the in vitro susceptibility of certain emerging mold pathogens to anidulafungin.

Purpose of the Study:

  • To assess the in vitro antifungal efficacy of anidulafungin.
  • To determine the activity spectrum of anidulafungin against a panel of clinically relevant mold isolates.

Main Methods:

  • In vitro susceptibility testing was performed on selected mold isolates.
  • Anidulafungin's inhibitory concentrations were determined against various fungal species.

Main Results:

  • Anidulafungin exhibited promising in vitro activity against Bipolaris spicifera.
  • Effective activity was also observed against Exophiala jeanselmei, Fonsecaea pedrosoi, Madurella mycetomatis, Penicillium marneffei, Phialophora verrucosa, Pseudallescheria boydii, Sporothrix schenckii, and Wangiella dermatitidis.

Conclusions:

  • Anidulafungin demonstrates broad-spectrum in vitro activity against a range of medically important molds.
  • These findings support further investigation of anidulafungin for treating mold-related infections.